Timing Optional Monitoring guidance is trial-informed and pathway-based because cagrilintide is not an approved stand-alone medication with a mature clinical monitoring label
18 The prescribing information for oral semaglutide notes that the most common side effects with use include nausea, abdominal pain, diarrhea, decreased appetite, vomiting, and constipation
Tsaousidou E, Paeger L, Belgardt BF, Pal M, Wunderlich CM, Brnneke H, Collienne U, Hampel B, Wunderlich FT, Schmidt-Supprian M, Kloppenburg P, Brning JC (2014) Distinct roles for JNK and IKK activation in Agouti-related peptide neurons in the development of obesity and insulin resistance
Multiple studies have demonstrated that patients with MAFLD are at an increased risk of developing heart failure (HF) compared to those without MAFLD
Interestingly, we find that HNRNPA1, an RNA processing protein that regulates both PKM2 splicing 7 and miR18a processing 33, is upregulated in LT2MYC tumors in a MYCdependent manner (Fig EV4C)